DK0954529T3 - Porphyromonas gingivalis-antigener til diagnose og behandling af rodbetændelse - Google Patents

Porphyromonas gingivalis-antigener til diagnose og behandling af rodbetændelse

Info

Publication number
DK0954529T3
DK0954529T3 DK97913999T DK97913999T DK0954529T3 DK 0954529 T3 DK0954529 T3 DK 0954529T3 DK 97913999 T DK97913999 T DK 97913999T DK 97913999 T DK97913999 T DK 97913999T DK 0954529 T3 DK0954529 T3 DK 0954529T3
Authority
DK
Denmark
Prior art keywords
antigen
gingivalis
amino acid
acid sequence
internal amino
Prior art date
Application number
DK97913999T
Other languages
English (en)
Inventor
Eric Charles Reynolds
Nada Slakeski
Anne Hendtlass
Original Assignee
Univ Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Melbourne filed Critical Univ Melbourne
Application granted granted Critical
Publication of DK0954529T3 publication Critical patent/DK0954529T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56955Bacteria involved in periodontal diseases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
DK97913999T 1996-03-29 1997-04-01 Porphyromonas gingivalis-antigener til diagnose og behandling af rodbetændelse DK0954529T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPN9012A AUPN901296A0 (en) 1996-03-29 1996-03-29 Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
PCT/AU1997/000212 WO1997036923A1 (en) 1996-03-29 1997-04-01 Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis

Publications (1)

Publication Number Publication Date
DK0954529T3 true DK0954529T3 (da) 2008-09-29

Family

ID=3793326

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97913999T DK0954529T3 (da) 1996-03-29 1997-04-01 Porphyromonas gingivalis-antigener til diagnose og behandling af rodbetændelse

Country Status (12)

Country Link
US (1) US6528038B1 (da)
EP (1) EP0954529B1 (da)
JP (1) JP4358909B2 (da)
KR (1) KR100527070B1 (da)
AT (1) ATE398137T1 (da)
AU (1) AUPN901296A0 (da)
CA (1) CA2249746C (da)
DE (1) DE69738770D1 (da)
DK (1) DK0954529T3 (da)
NZ (1) NZ331557A (da)
WO (1) WO1997036923A1 (da)
ZA (1) ZA972757B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO652897A0 (en) 1997-04-30 1997-05-29 University Of Melbourne, The Synthetic peptide constructs for the diagnosis and treatment of periodontitis
US8129500B2 (en) * 1997-12-10 2012-03-06 Csl Limited Porphyromonas gingivalis polypeptides and nucleotides
EP2264176A1 (en) * 1997-12-10 2010-12-22 CSL Limited Porphorymonas gingivalis polypeptides and polynucleotides
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
AUPP893999A0 (en) * 1999-03-01 1999-03-25 Csl Limited Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis
DE60126768T2 (de) * 2000-06-16 2007-10-25 Baylor Research Institute, Dallas ADJUVANTIEN UND VERFAHREN ZUR INDUKTION EINER Th2 IMMUNANTWORT
JP5469785B2 (ja) * 2004-02-06 2014-04-16 有限会社 ミクロデント ポルフィロモナスジンジバリス試薬
WO2006084129A2 (en) * 2005-02-01 2006-08-10 University Of Florida Research Foundation Genes of porphyromonas gingivalis w83 involved in invasion of human cells
CA2652957A1 (en) 2006-06-27 2008-01-03 Oral Health Australia Pty Ltd. Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease
WO2009006699A1 (en) * 2007-07-12 2009-01-15 Oral Health Australia Pty Ltd Biofilm treatment
EP2176413A4 (en) 2007-07-12 2012-08-01 Oral Health Australia Pty Ltd IMMUNOLOGY TREATMENT FOR BIOFILMS
CN107266582B (zh) 2008-08-29 2021-09-10 口腔健康澳洲私人有限公司 牙龈卟啉单胞菌感染的预防、治疗和诊断
CA2769231A1 (en) * 2009-08-02 2011-02-10 Sanofi Pasteur Limited Porphyromonas gingivalis polypeptides
US8140041B2 (en) * 2009-08-27 2012-03-20 Mediatek Inc. Tunable capacitive device with linearization technique employed therein
KR102037969B1 (ko) * 2019-07-25 2019-10-29 주식회사 하이센스바이오 신규한 펩타이드

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60142915A (ja) * 1983-12-28 1985-07-29 Lion Corp 口腔用組成物
CA1282691C (en) * 1986-02-26 1991-04-09 Robert Joseph Genco Monoclonal antibodies useful in the identification of microorganisms causing periodontal disease
US5830710A (en) 1988-09-08 1998-11-03 University Of Florida Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease
US5399484A (en) * 1991-10-08 1995-03-21 Eastman Kodak Company Use of blocking protein with high pH extraction in method to determine a microorganism associated with periodontal disease and kit useful therefor
US5523390A (en) * 1993-09-10 1996-06-04 University Of Georgia Research Foundation, Inc. Porphyromonas gingivalis arginine-specific proteinase
JPH0797395A (ja) * 1993-09-28 1995-04-11 Kyowa Medex Co Ltd ポルフイロモナス・ジンジバリス線毛蛋白質の配列を含有するペプチド類及びその用途
AU7822394A (en) * 1993-10-08 1995-05-04 Lion Corporation Fimbrillin protein of porphyromonas gingivalis
DE69527514T2 (de) * 1994-03-29 2003-04-03 Kyowa Hakko Kogyo Co., Ltd. Gen eines zelloberflächenpolypeptids

Also Published As

Publication number Publication date
JP2001501808A (ja) 2001-02-13
EP0954529B1 (en) 2008-06-11
NZ331557A (en) 1999-11-29
EP0954529A4 (en) 2003-02-05
US6528038B1 (en) 2003-03-04
CA2249746A1 (en) 1997-10-09
KR100527070B1 (ko) 2006-06-29
CA2249746C (en) 2012-06-12
WO1997036923A1 (en) 1997-10-09
EP0954529A1 (en) 1999-11-10
KR19990087436A (ko) 1999-12-27
DE69738770D1 (de) 2008-07-24
ATE398137T1 (de) 2008-07-15
JP4358909B2 (ja) 2009-11-04
ZA972757B (en) 1998-01-30
AUPN901296A0 (en) 1996-04-26

Similar Documents

Publication Publication Date Title
DK0954529T3 (da) Porphyromonas gingivalis-antigener til diagnose og behandling af rodbetændelse
DK1090039T3 (da) Peptidsammensætning som immunogen til behandling af allergi
DE69433663D1 (de) Antikörper gegen menschliches prostatspezifisches drüsenkallikrein
ES8801318A1 (es) Un procedimiento para la produccion de un peptido.
RU93058676A (ru) Оральное лечение геликобактерной инфекции
DE69324487D1 (de) Rezeptorbindende region des diphtherietoxius
TR199801722T2 (xx) Peptit imm�nojenler.
RU95105991A (ru) Конъюгат, вакцина, способы усиления иммуногенности, способы иммунизации
DK0671927T3 (da) Neutraliserende humane monoklonale antistoffer mod respiratorisk syncytialvirus
EP1630229A3 (en) Melanoma antigens
BR9810907A (pt) Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico
HUP9903770A2 (hu) Eljárások és készítmények többepitópos antigének konformációjának megváltoztatására immunválasz kiváltása céljából
WO1996021734A3 (en) P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
HUP9901688A2 (hu) A diabétesz kezelésére szolgáló, humán hősokk protein 60-ból származó új peptidek, készítmények, eljárások és kitek
FI900230A0 (fi) Anti-idiotypa antikroppar mot antikroppar mot antigener med hoeg molekylvikt associerade till human melanoma.
GB9501826D0 (en) Polypeptide fragments
ATE329615T1 (de) Borrelia burgdorferi bacterin
DK0809653T3 (da) Helicobacter pylori-antigen
DK0513565T3 (da) Monoklonale antistoffer mod plasmin-antiplasmin-komplekset, fremgangsmåde til deres fremstilling og deres anvendelse
IT1276453B1 (it) Vaccino/composizioni terapautica di helycobacter pylori, loro preparazione ed impiego.
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов